Technology
Spiderwort Biotechnologies’ proprietary technology uses cellulose-based biomaterials to engineer scaffolds for a variety of groundbreaking regenerative medicine applications.
Spiderwort Biotechnologies’ dermal filler and spinal cord injury medical device research represent promising developments in biotechnology and the future of medicine.

Products
Spiderwort Biotechnologies’ proprietary plant-based biomaterial platform provides a potential framework for significant advances in regenerative medicine, tissue engineering, and medical aesthetics.

CelluBridge
CelluBridge™ is a cellulose-based scaffold under development to support repair and regeneration of the spinal cord.
Learn more about CelluBridge
CelluJuve
CelluJuve® is a cellulose-based dermal filler under development to support facial tissue augmentation and rejuvenation.
Learn more about CelluJuve
Video
Could we treat spinal cord injuries with asparagus? | TED
Spiderwort Biotechnologies’ Chief Science Officer explains how we leverage cellulose-based biomaterials to develop regenerative medicine.
Video Play button - Could we treat spinal cord injuries with asparagus? | TED